Cite

HARVARD Citation

    Druedahl, L. et al. (2020). ELSI Implications of Prioritizing Biological Therapies in Times of COVID-19. Journal of law, medicine & ethics. 48 (3), pp. 579-582. [Online]. 
  
Back to record